Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?
Staudacher AH, Brown MP. · 2017
Read Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required? by Staudacher AH, Brown MP. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5729478.txt.
Description
Staudacher and Brown ask how antibody drug conjugates kill nearby cancer cells. Such drugs pair a tumor seeking antibody with a strong cell killing payload. A linker joins the two parts and controls drug release. Released drug can drift into nearby cells, a process called bystander killing.
The review checks whether the conjugate must first be taken inside a target cell. Older views held that entry, linker cutting, and release inside were all required. Newer work shows some linker and drug pairs can be cut outside the cell instead. The authors use two approved drugs to show both paths at work.
Catalog record
| CREATOR | Staudacher AH, Brown MP. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |